March 2014

Publications for March 2014

Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of child-bearing age and postpartum women.

Beth Halperin, Scott A. Halperin, Donna MacKinnon-Cameron , Donna MacDougall, Jill Mutch, Joanne M. Langley and Shelly McNeil

Clin Infect Dis. , 2011;53:885–892. doi: 10.1093/cid/cir538

Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4–5 years after a previous dose.

Scott A. Halperin, Shelly McNeil and Joanne M. Langley

Vaccine , . 2011;29:8459–8465. doi: 10.1016/j.vaccine.2011.07.068

Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets.

Scott A. Halperin

Vaccine , 2011;29:7718–7726. doi: 10.1016/j.vaccine.2011.07.135

Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months.

Scott A. Halperin

Pediatrics. , 2011;128:e276–e289. doi: 10.1542/peds.2010-2777

Regulation of D-alanylation of lipoteichoic acid in Streptococcus gordonii.

Scott A. Halperin and Song F. Lee

Microbiology , 2011;157(Pt 8):2248–2256. doi:10.1099/mic.0.048140-0

Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis.

Scott A. Halperin

Vaccine , 2011;29:6540–6548. doi: 10.1016/j.vaccine.2011.07.009

The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 vaccine.

Scott A. Halperin

CMAJ , 2011; 183:e1033–e1037. doi: 10.1503/cmaj.110196

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6, and 12–14 months of age.

Scott A. Halperin

Vaccine , 2011;29:1324–1331. doi: 10.1016/j.vaccine.2010.11.053

Evaluation of adjuvanted Pandemic H1N12009 influenza vaccine after one and two doses in young children.

Joanne M. Langley and Scott A. Halperin

Pediatr Infect Dis J. , 2011;30:402–407. doi: 10.1097/INF.0b01323182068f33

Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.

Scott A. Halperin

Vaccine , 2011;29:1595–1604. doi: 10.1016/j.vaccine.2010.12.083